Bristol Myers Squibb (CELG-RI) FCF Payout Ratio (2009 - 2026)

Bristol Myers Squibb (CELG-RI) has 18 years of FCF Payout Ratio data on file, last reported at 1.69 in Q1 2026.

• FCF Payout Ratio for Q1 2026 came in at 1.69, up 128.23% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.43 (up 13.5% YoY), and the FY2025 annual result was 0.39, up 12.6% from the prior year.
• FCF Payout Ratio rose to 1.69 in Q1 2026 per CELG-RI's latest filing, from 0.79 in the prior quarter.
• Over five years, FCF Payout Ratio peaked at 1.69 in Q1 2026 and troughed at 0.01 in Q2 2022.
• A 5-year average of 0.48 and a median of 0.35 in 2025 frame the typical range for FCF Payout Ratio.
• The sharpest annual moves came in 2023 and 2025: FCF Payout Ratio surged 12086.9% in 2023, then tumbled 39.81% in 2025.
• A 5-year view of FCF Payout Ratio shows it stood at 0.39 in 2022, then fell by 23.54% to 0.3 in 2023, then gained by 1.41% to 0.3 in 2024, then jumped by 162.33% to 0.79 in 2025, then surged by 115.41% to 1.69 in 2026.
• Business Quant data shows CELG-RI's FCF Payout Ratio at 1.69 in Q1 2026, 0.79 in Q4 2025, and 0.21 in Q3 2025.